Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
307-04-008 ISMRM Abstract

Stratified Prognostic Value of Myocardial Fibrosis by LGE in CRT: Non-Linear Relationship and Threshold-Based Risk Prediction

Accepted
Shuang Li1, Baiyan Zhuang1, Zhao Wang2, BingYan Shu1, Chen Cui3, jianxiu lian 4, Qingyuan Li1, Wei Chen1, Yue Ren1, Koen Nieman5, Lei Xu1
1Beijing Anzhen Hospital, Capital Medical University, Beijing, China
2Peking University Third Hospital, Beijing, China
3Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
4Philips Healthcare, Guangzhou, China
5Stanford University, Stanford, United States of America
Presenting Author: jianxiu lian

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol. 2007;100(11):1665-70.https://doi.org/10.1016/j.amjcard.2007.06.071 [doi]
2. Chen Z, Ma X, Gao Y, et al. Cardiac magnetic resonance-derived myocardial scar is associated with echocardiographic response and clinical prognosis of left bundle branch area pacing for cardiac resynchronization therapy. Europace. 2023;25(11).https://doi.org/10.1093/europace/euad326 [doi]
3. Bazoukis G, Hui JMH, Lee YHA, et al. The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy - a systematic review of the literature. Heart Fail Rev. 2022;27(6):2095-118.https://doi.org/10.1007/s10741-022-10263-5 [doi]
4. Unger A, Garot J, Toupin S, et al. Prognostic Value of Cardiac MRI Late Gadolinium Enhancement Granularity in Participants with Ischemic Cardiomyopathy. Radiology. 2025;314(1):e240806.https://doi.org/10.1148/radiol.240806 [doi]
5. White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol. 2006;48(10):1953-60.https://doi.org/10.1016/j.jacc.2006.07.046 [doi]
6. Prinzen FW, Vernooy K, Auricchio A. Cardiac resynchronization therapy: state-of-the-art of current applications, guidelines, ongoing trials, and areas of controversy. Circulation. 2013;128(22):2407-18.https://doi.org/10.1161/CIRCULATIONAHA.112.000112 [doi]
7. Leyva F, Foley PW, Chalil S, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13(1):29.https://doi.org/10.1186/1532-429X-13-29 [doi]
8. Leyva F, Zegard A, Acquaye E, et al. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy. J Am Coll Cardiol. 2017;70(10):1216-27.https://doi.org/10.1016/j.jacc.2017.07.712 [doi]
9. Chalil S, Foley PW, Muyhaldeen SA, et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace. 2007;9(11):1031-7.https://doi.org/10.1093/europace/eum133 [doi]

Cite this abstract